Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Colossal Biosciences

Colossal Launches The Colossal Foundation
From Colossal Biosciences
Via Business Wire
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
From Colossal Biosciences
Via Business Wire
Plastic Degradation Company, Breaking, Emerges from Stealth with Naturally-Derived Solution to Degrade Multiple Plastics with $10.5M in Seed Funding
From Colossal Biosciences
Via Business Wire
Re:wild and Colossal Biosciences team up to leverage revolutionary technology to save critically endangered species on the brink of extinction
From Colossal Biosciences
Via Business Wire
World-Renowned Ancient DNA Expert, HHMI Investigator, and MacArthur Award Winner Beth Shapiro, Ph.D., Joins Colossal as Chief Science Officer
From Colossal Biosciences
Via Business Wire
Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project
From Colossal Biosciences
Via Business Wire
Oscar-Award Winning ‘My Octopus Teacher’ Nature Documentarian James Reed to Make Docuseries About De-Extinction Company Colossal, to be Produced by Underdog Films and Teton Ridge Entertainment
From Colossal Biosciences
Via Business Wire
Colossal Biosciences Names Emily Castel as Chief Marketing Officer
From Colossal Biosciences
Via Business Wire
Colossal Announces the Tasmania Thylacine Advisory Committee
From Colossal Biosciences
Via Business Wire
Mauritian Wildlife Foundation Partners With Colossal Biosciences to Rewild the Dodo to Its Native Habitat
From Colossal Biosciences
Via Business Wire
Colossal Biosciences and Save the Elephants Debut First-of-its-Kind Project to Utilize Drones and Machine Learning for Elephant Conservation
From Colossal Biosciences
Via Business Wire
Colossal Biosciences Joins BioRescue in Its Mission to Save the Northern White Rhino From Extinction
From Colossal Biosciences
Via Business Wire
Colossal Biosciences “Mammoth in the Classroom” Initiative, as Part of University of Alaska Fairbanks Adopt a Mammoth Program, Has Reached Its Initial Research and Adoption Goal
From Colossal Biosciences
Via Business Wire
Colossal Biosciences Launches Partnership with Elephant Havens Wildlife Foundation to Develop New Models for the Successful Reintroduction of Orphan Elephants Using AI
From Colossal Biosciences
Via Business Wire
Colossal Biosciences Named to TIME’s List of the TIME100 Most Influential Companies
From Colossal Biosciences
Via Business Wire
Colossal Biosciences and the Vertebrate Genomes Project Publish the First Near Complete African Elephant Chromosome Level Genome
From Colossal Biosciences
Via Business Wire
Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo
From Colossal Biosciences
Via Business Wire
Colossal Accelerates Research and Development of Life-Saving Vaccine to Prevent Elephant Extinction
From Colossal Biosciences
Via Business Wire
Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences
From Colossal Biosciences
Via Business Wire
Colossal to De-Extinct the Thylacine, also known as the Tasmanian Tiger, an Iconic Australian Marsupial That Has Been Extinct Since 1936
From Colossal Biosciences
Via Business Wire
Colossal Biosciences and the Vertebrate Genomes Project Sequence the Asian Elephant Genome, Chromosome to Chromosome
From Colossal Biosciences
Via Business Wire
Colossal Named a Technology Pioneer by World Economic Forum
From Colossal Biosciences
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.